including Bayer AG and Novartis are exploring a deal for Merck & Co Inc’s consumer healthcare business‚ as they seek to gain scale in a fragmented industry‚ according to several people familiar with the matter. Reckitt Benckiser Group PLC and Procter & Gamble Co are also among the parties that have held discussions with Merck about buying the unit‚ best known for Coppertone sunscreen and Claritin allergy medicine‚ the sources said this week. The Merck business‚ which also includes Dr. Scholl’s foot
Premium Pharmacology Marketing Pharmacy
MERCK SHARPE & DOHME CASE SUMMARY QUESTIONS 1. Provide brief Background and Context In 1996 Merc Sharp & Dohme (MSD)‚ one of the top tier pharmaceutical firms in Argentina was undergoing fundamental changes in both its organizational structure as well as managerial philosophy. For over a year the company was under a new managing director who was leading the transformation of the company. The main goals at the time were to change the old hierarchical management system into a flatter
Premium Ethics Management
c. Moody’s Investors Service downgraded the long-term senior unsecured rating of AZN from A1 to Aa2 in 2007. Assess any potential association between this downgrade and AZN’s arrangements with Merck. Paris‚ July 30‚ 2007 -- Moody’s Investors Service downgraded the long-term senior unsecured ratings of AstraZeneca plc and its guaranteed subsidiary to A1 from Aa2. This downgrade followed the announcement of AstraZeneca’s acquisition of MedImmune for a total consideration of more than US$15 billion
Premium Money
Merck and Co. and river blindness MANUEL VELASQUEZ‚ Business Ethics. Concepts and cases 4th edt.‚ Prentice Hall‚ Upper Saddle River‚ New Jersey‚ 1998 River blindness is an agonizing disease that affects some 18 million impoverished people living in remote villages along the banks of rivers in tropical regions of Africa and Latin America. The disease is caused by a tiny parasitic worm that is passed from person to person by the bite of the black fly which breeds in river waters. The tiny worms
Premium Pharmaceutical industry Ethics Drug discovery
Running head: CASE STUDY: MERCK & COMPANY: THE VIOXX RECALL Merck & Company: The Vioxx Recall Albert Balogun California Baptist University BUS 520A: Managerial Ethics Jim Bishop‚ PhD June 30‚ 2010 Merck & Company: The Vioxx Recall The issues involved in Merck‚ a pharmaceutical manufacturing company’s recall of one its products‚ Vioxx‚ is the effect of direct-to-consumer (DTC) advertising of prescription drug on the society public
Premium Pharmacology Food and Drug Administration Pharmaceutical industry
Merck and Company‚ Inc.: SWOT Analysis and Stakeholder Evaluation Merck and Company‚ Inc.‚ a.k.a. Merck‚ is a leading worldwide pharmaceutical company that engages in manufacturing and marketing medicines‚ animal products‚ vaccines‚ and consumer health products. As most companies‚ Merck desires to continue their success as one of the top health care innovators in the world. Conducting a SWOT analysis can give them insight into internal strengths and weaknesses as well as external opportunities
Premium Pharmaceutical industry Marketing
How to Download and Analyze a Case How to download the Harvard Business School Cases Enter the following link into your web browser: http://harvardbusinessonline.hbsp.harvard.edu/relay.jhtml?name=cp&c=c24832 To get the Harvard Online Course materials you need to register as a new user (unless you already have registered). The Harvard Online Course may ask you for a "Reference ID" That number is “c24832”. Then just click "Add to my Courses" and you’ll be able to purchase the
Premium Marketing Strategic management Sales management
Evaluating Merck & Co.‚ Inc vs. Pfizer‚ Inc. Amy Lan Lan Liu Connor Buestad Raghul Subramanian Natalia Cosa ACCT 831 March 16‚ 2011 Table of Contents: Part 1: History‚ Background and Core Business …...................................................................2 a. Merck & Co.‚ Inc. ….............................................................................................................. 2 b. Pfizer
Premium Pharmaceutical industry Pharmacology Generic drug
MGT 4083-Technology Strategy Case Analysis Merck & Co.: Evaluating a Drug Licensing Opportunity Introduction: Davanrik is a new drug developed by LAB Pharmaceuticals‚ which has the potential to treat depression and obesity. Davanrik was initially developed to treat depression by stimulating the receptor in the serotonin system that promotes anti-depression. However‚ it was discovered that Davanrik also blocks the receptor that causes hunger. LAB Pharmaceuticals obtained a patent for Davanrik
Premium
Merck and River Blindness (Onchocerciasis) In understanding the decision Merck made to donate medicines‚ we need to start by understanding the motivations and core values behind the company that undertook the actions. We can get some insight into these by examining and understanding their company mission statement: The mission of Merck is to provide society with superior products and services‚ innovations‚ and solutions that improve the quality of life and satisfy customer needs-to provide employees
Premium Water Water pollution Kidney